Literature DB >> 7526001

The significance of isoechoic prostatic carcinoma.

W J Ellis1, M K Brawer.   

Abstract

The diagnosis of prostatic carcinoma is most commonly made today by transrectal ultrasound guided needle biopsy. Often hypoechoic and peripheral zone lesions are the only areas sampled. Recently, we showed that this approach missed a quarter of the cancers that would be detected by a systematic biopsy technique. We term these missed cancers isoechoic carcinomas. We reviewed 1,549 systematic sextant prostate needle biopsies, of which 417 cancers were detected and subdivided into hypoechoic cancers (cancers detected on biopsy of a hypoechoic sector and isoechoic cancers (cancers found only in normal [isoechoic] peripheral zone). We noted in men with only isoechoic cancers that fewer biopsy cores per prostate revealed cancer (mean 1.6 versus 3.0, p < 0.0001) and that these men had lower serum prostate specific antigen levels (mean 14.4 versus 43.7, p < 0.001). The Gleason scores for the isoechoic and hypoechoic cancers were indistinguishable. The pathological staging of hypoechoic and isoechoic cancers was also similar. This study suggests that while isoechoic cancers are generally smaller than hypoechoic cancers, they do not represent low grade clinically insignificant carcinomas. A systematic approach to performing prostate biopsy is recommended.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526001     DOI: 10.1016/s0022-5347(17)31663-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

2.  [Transrectal ultrasound of the prostate. Current status and prospects].

Authors:  M Zacharias; K V Jenderka; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

Review 3.  Three dimensional ultrasound and prostate cancer.

Authors:  S S Mehta; A R Azzouzi; F C Hamdy
Journal:  World J Urol       Date:  2004-11-12       Impact factor: 4.226

4.  MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland.

Authors:  Stephan Zangos; Christopher Herzog; Katrin Eichler; Renate Hammerstingl; Andreas Lukoschek; Stefanie Guthmann; Bernd Gutmann; Uwe Joseph Schoepf; Phillip Costello; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-10-10       Impact factor: 5.315

5.  Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients.

Authors:  Gökhan Sönmez; Şevket Tolga Tombul; Hakan İmamoğlu; Hülya Akgün; Abdullah Demirtaş; Atila Tatlışen
Journal:  Turk J Urol       Date:  2019-02-20

Review 6.  Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.

Authors:  Tobias Penzkofer; Clare M Tempany-Afdhal
Journal:  NMR Biomed       Date:  2013-09-03       Impact factor: 4.044

Review 7.  Ultrasound findings are not useful for defining stage T1c prostate cancer.

Authors:  H Sanders; R el-Galley
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

8.  Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.

Authors:  Tillmann Loch; Ursula Eppelmann; Jan Lehmann; Bernd Wullich; Annemie Loch; Michael Stöckle
Journal:  World J Urol       Date:  2004-12-01       Impact factor: 4.226

Review 9.  [Prostate carcinoma].

Authors:  H-P Schlemmer
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

10.  Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2007-08-11       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.